Big Upcoming Catalysts for these 2 Small Biotechs: Agenus Inc. (NASDAQ: AGEN), Protalix BioTherapeutics (NYSE: PLX)

One thing that I have developed over the past couple of decades investing in the small biotech space is learning to recognize when a company and its stock start to have positive catalysts happening and also on the horizon. This is critical in spotting potential big winners in the market.
In spring of last year I noticed that Avanir Pharmaceuticals (NASDAQ: AVNR) had just won a major court victory to retain exclusivity on its primary drug through 2026 and also had phase II trial results coming up later on in the year for a promising compound to treat the agitation commonly found in Alzheimer’s patients. When results turned out to be positive a few months later, the stock shot up. Soon thereafter, the company received a substantial buyout offer from a bigger Japanese based pharma player in December bringing better than a 215% return to the Small Cap Gems portfolio. (more)

Please share this article